Letko, Brosseau & Associates’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $47M | Sell |
|
|||||
|
2025
Q2 | $59.2M | Sell |
|
|||||
|
2025
Q1 | $61.5M | Sell |
|
|||||
|
2024
Q4 | $55.3M | Sell |
|
|||||
|
2024
Q3 | $81.8M | Buy |
|
|||||
|
2024
Q2 | $66.4M | Buy |
|
|||||
|
2024
Q1 | $69.6M | Buy |
|
|||||
|
2023
Q4 | $76.7M | Sell |
|
|||||
|
2023
Q3 | $72.8M | Sell |
|
|||||
|
2023
Q2 | $75M | Sell |
|
|||||
|
2023
Q1 | $81.6M | Sell |
|
|||||
|
2022
Q4 | $86M | Sell |
|
|||||
|
2022
Q3 | $81.6M | Sell |
|
|||||
|
2022
Q2 | $83.6M | Buy |
|
|||||
|
2022
Q1 | $69.3M | Sell |
|
|||||
|
2021
Q4 | $86.2M | Sell |
|
|||||
|
2021
Q3 | $83.5M | Sell |
|
|||||
|
2021
Q2 | $86.3M | Sell |
|
|||||
|
2021
Q1 | $81.7M | Buy |
|
|||||
|
2020
Q4 | $66.3M | Sell |
|
|||||
|
2020
Q3 | $80.6M | Sell |
|
|||||
|
2020
Q2 | $110M | Sell |
|
|||||
|
2020
Q1 | $116M | Sell |
|
|||||
|
2019
Q4 | $102M | Buy |
|
|||||
|
2019
Q3 | $88.9M | Buy |
|
|||||
|
2019
Q2 | $93.1M | Sell |
|
|||||
|
2019
Q1 | $92.2M | Buy |
|
|||||
|
2018
Q4 | $87.7M | Buy |
|
|||||
|
2018
Q3 | $108M | Sell |
|
|||||
|
2018
Q2 | $101M | Buy |
|
|||||
|
2018
Q1 | $104M | Sell |
|
|||||
|
2017
Q4 | $99.1M | Sell |
|
|||||
|
2017
Q3 | $113M | Buy |
|
|||||
|
2017
Q2 | $98.5M | Buy |
|
|||||
|
2017
Q1 | $93.8M | Sell |
|
|||||
|
2016
Q4 | $100M | Sell |
|
|||||
|
2016
Q3 | $117M | Sell |
|
|||||
|
2016
Q2 | $125M | Buy |
|
|||||
|
2016
Q1 | $137M | Sell |
|
|||||
|
2015
Q4 | $155M | Sell |
|
|||||
|
2015
Q3 | $157M | Sell |
|
|||||
|
2015
Q2 | $188M | Sell |
|
|||||
|
2015
Q1 | $157M | Buy |
|
|||||
|
2014
Q4 | $147M | Buy |
|
|||||
|
2014
Q3 | $103M | Sell |
|
|||||
|
2014
Q2 | $80.7M | Buy |
|